Skip to main content

Opthea Ltd

CYVNY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001815620

No open-market purchases or sales by Opthea Ltd insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesCKDXF

13F holders, Q2 2025

Institutional positions in Opthea Ltd as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
8
−1 vs. Q1 2025
Shares held
7.46M
−46.4K (−0.6%) vs. Q1 2025
Total value
$393.2K
−$220.3K (−35.9%) vs. Q1 2025
New holders
1
0 more added
Sold out
2
0 more reduced

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CYVNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 8 institutions
Q1 2021: 8 institutionsQ2 2021: 9 institutionsQ3 2021: 8 institutionsQ4 2021: 9 institutionsQ1 2022: 8 institutionsQ2 2022: 8 institutionsQ3 2022: 9 institutionsQ4 2022: 9 institutionsQ1 2023: 12 institutionsQ2 2023: 9 institutionsQ3 2023: 9 institutionsQ4 2023: 11 institutionsQ1 2024: 8 institutionsQ2 2024: 9 institutionsQ3 2024: 7 institutionsQ4 2024: 11 institutionsQ1 2025: 9 institutionsQ2 2025: 8 institutionsQ3 2025: 6 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2025: $393.2K
Q1 2021: $54.2MQ2 2021: $45.6MQ3 2021: $46.0MQ4 2021: $42.5MQ1 2022: $33.7MQ2 2022: $50.7MQ3 2022: $50.1MQ4 2022: $41.3MQ1 2023: $29.9MQ2 2023: $20.7MQ3 2023: $12.7MQ4 2023: $21.1MQ1 2024: $27.5MQ2 2024: $12.2MQ3 2024: $21.3MQ4 2024: $21.2MQ1 2025: $613.4KQ2 2025: $393.2KQ3 2025: $64.2KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CYVNY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20256$64.2K
Q2 20258$393.2K
Q1 20259$613.4K
Q4 202411$21.2M
Q3 20247$21.3M
Q2 20249$12.2M
Q1 20248$27.5M
Q4 202311$21.1M
Q3 20239$12.7M
Q2 20239$20.7M
Q1 202312$29.9M
Q4 20229$41.3M
Q3 20229$50.1M
Q2 20228$50.7M
Q1 20228$33.7M
Q4 20219$42.5M
Q3 20218$46.0M
Q2 20219$45.6M
Q1 20218$54.2M

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Opthea Ltd; share changes are against Q1 2025.

Institutions holding CYVNY in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
HSBC Holdings PLC105,939$356.0K0.00%00.0%Unchanged
UBS Group AG7,773$26.5K0.00%00.0%Unchanged
Millennium Management LLC48,329$8.12K0.00%00.0%Unchanged
Morgan Stanley765$2.57K0.00%00.0%Unchanged
EP Wealth Advisors, LLC10,000$00.00%00.0%Unchanged
Baker Bros. Advisors LP2,087,320$00.00%00.0%Unchanged
VGI Partners Ltd5,193,688$00.00%00.0%Unchanged
Raymond James Financial Inc5,954$00.00%+5,954New
Twin Lakes Capital Management, LLC0$00.00%−33,156−100.0%Sold out
Old Mission Capital LLC0$00.00%−19,167−100.0%Sold out